Celestica, Inc (CLS) concluded trading on Thursday at a closing price of $110.72, with 3.47 million shares of worth about $384.34 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 94.79% during that period and on January 16, 2025 the price saw a gain of about 3.00%. Currently the company’s common shares owned by public are about 118.60M shares, out of which, 115.62M shares are available for trading.
Stock saw a price change of 8.05% in past 5 days and over the past one month there was a price change of 11.61%. Year-to-date (YTD), CLS shares are showing a performance of 19.96% which increased to 288.35% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $26.62 but also hit the highest price of $108.25 during that period. The average intraday trading volume for Celestica, Inc shares is 2.33 million. The stock is currently trading 12.53% above its 20-day simple moving average (SMA20), while that difference is up 21.17% for SMA50 and it goes to 77.71% higher than SMA200.
Celestica, Inc (NYSE: CLS) currently have 118.60M outstanding shares and institutions hold larger chunk of about 76.28% of that.
The stock has a current market capitalization of $12.88B and its 3Y-monthly beta is at 2.26. PE ratio of stock for trailing 12 months is 35.01, while it has posted earnings per share of $3.16 in the same period. Its PEG reads 1.14 and has Quick Ratio of 0.87 while making debt-to-equity ratio of 0.52. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CLS, volatility over the week remained 5.02% while standing at 4.61% over the month.
Stock’s fiscal year EPS is expected to rise by 58.78% while it is estimated to increase by 15.80% in next year. EPS is likely to grow at an annualized rate of 30.70% for next 5-years, compared to annual growth of 23.48% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by UBS on November 22, 2024 offering a Neutral rating for the stock and assigned a target price of $95 to it. Coverage by Barclays stated Celestica, Inc (CLS) stock as an Overweight in their note to investors on November 05, 2024, suggesting a price target of $91 for the stock. On September 09, 2024, Stifel Upgrade their recommendations, while on May 15, 2024, Fox Advisors Initiated their ratings for the stock with a price target of $60. Stock get a Neutral rating from CIBC on April 26, 2024.
